Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease.
Mittermeyer G, Christine CW, Rosenbluth KH, Baker SL, Starr P, Larson P, Kaplan PL, Forsayeth J, Aminoff MJ, Bankiewicz KS.
Mittermeyer G, et al.
Hum Gene Ther. 2012 Apr;23(4):377-81. doi: 10.1089/hum.2011.220. Epub 2012 Apr 10.
Hum Gene Ther. 2012.
PMID: 22424171
Free PMC article.
Clinical Trial.